Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls

Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls

Type 1 diabetes is recognized as an autoimmune inflammatory disease and low grade inflammation is also observed in type 2 diabetic patients. Interleukin 17 (IL-17) is a new player in inflammation. Th17 cells, as the main source of IL-17, require transforming growth factor β (TGF-β) and interleukin 2...

Full description

Bibliographic Details
Main Authors: Azam Roohi, Mina Tabrizi, Farzaneh Abbasi, Asal Ataie-Jafari, Behrouz Nikbin, Bagher Larijani, Mostafa Qorbani, Alipasha Meysamie, Hossein Asgarian-Omran, Bahram Nikmanesh, Arezou Bajouri, Novin Shafiey, Akram Maleki
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/718946

Internet

http://dx.doi.org/10.1155/2014/718946

Similar Items